Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bavarian Nordic A/S (OP: BVNKF ) 35.59 UNCHANGED Streaming Delayed Price Updated: 12:00 PM EDT, Sep 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Bavarian Nordic A/S UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat September 17, 2024 The UK government has purchased 150,000 mpox vaccine doses from Bavarian Nordic, enhancing its response to clade I mpox, while partnering with WHO and UNICEF. Via Benzinga Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows September 06, 2024 Moderna is conducting a Phase 1/2 trial of mRNA-1769, a potential mpox vaccine for adults. Early research shows it may outperform Bavarian Nordic's Jynneos in reducing severe disease in monkeys. Via Benzinga Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic September 06, 2024 The European Commission's first delivery of mpox vaccines to Congo aims to combat the outbreak, despite challenges in distribution and approval. Via Benzinga Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain August 26, 2024 Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Quest Diagnostics are also monitoring demand and expanding testing... Via Benzinga Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency August 16, 2024 Bavarian Nordic submits data to European Medicines Agency seeking approval to extend Imvanex vaccine use to adolescents. New trials in younger children planned as global demand for smallpox and mpox... Via Benzinga Bavarian Nordic Recruits US Firm For Packaging Services For Its Monkeypox Vaccine August 19, 2022 Via Benzinga Bavarian Nordic's Monkeypox Vaccine Gets Thumbs Up From EU Regulator July 22, 2022 Via Benzinga Monkeypox Vaccine Maker Bavarian Nordic Bets $380M On Emergent Bio's Travel Vaccines February 15, 2023 Via Benzinga West Africa-Based Studies Show JNJ, Merck's Ebola Vaccines Provide Lasting Antibodies December 15, 2022 Via Benzinga Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa November 03, 2022 Researchers have warned that a dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa, which could trigger new global outbreaks. After analyzing 1,463 cases... Via Benzinga White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox September 02, 2022 Via Benzinga EU, Bavarian Nordic Ink Supply Pact For 110,000 Monkeypox Vaccines June 14, 2022 Via Benzinga Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed August 26, 2022 Via Benzinga SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report August 25, 2022 In an effort to prevent bioterrorism attacks, just in case, SIGA Technologies Inc (NASDAQ: SIGA) started working on the smallpox treatment, Tpoxx, after the 9/11 terrorist attack that shook the world.... Via Benzinga Bavarian Nordic Making All Efforts To Stretch Capacity To Boost Monkeypox Vaccine Supplies August 24, 2022 Bavarian Nordic A/S (OTC: BVNRY) said it was making "every effort" to meet the high demand for its monkeypox vaccine worldwide as it kept its business outlook for the year. Via Benzinga Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch August 23, 2022 The only FDA-approved monkeypox vaccine from Bavarian Nordic A/S (OTC: BVNY) is in short supply. Via Benzinga Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test August 19, 2022 Via Benzinga Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment August 18, 2022 Top Biden administration officials are poised to lay out new steps to accelerate the U.S. response amid the spread of monkeypox and demand for vaccines & treatments. Via Benzinga WeTrade Shares Soar On Collaboration Over Exclusive COVID-19 Omicron Disinfectant August 18, 2022 Via Benzinga A Biopharma Working On Malaria, Norovirus Vaccines Threw It's Hat In The Monkeypox Ring August 17, 2022 Blue Water Vaccines Inc (NASDAQ: BWV) Via Benzinga Benzinga Before The Bell: More Amazon Workers Join Union Over Pay and Work Conditions, UK Inflation Highest In 40 Years, Sole Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand And Other Top Financial Stories Wednesday, August 17 August 17, 2022 CNBC BlackRock To Pledge A$1B In Australian Battery Storage Assets – Report Via Benzinga The Only Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand August 17, 2022 Bavarian Nordic A/S (OTC: BVNKF), the only company with an approved vaccine for monkeypox, said it’s no longer sure it can meet demand as cases continue to rise worldwide, Via Benzinga Bavarian Nordic's Monkeypox Vaccine Scores EU Approval As WHO Declares Global Health Emergency July 25, 2022 Via Benzinga The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings July 19, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Bavarian Nordic Inks Multiple Supply Pact For Its Monkey pox Vaccine, Updates FY22 Guidance July 18, 2022 Via Benzinga Bavarian Nordic Launches COVID-19 Booster Study To Compare Against Pfizer/BioNTech Shot June 16, 2022 Via Benzinga This Famed Company Is Working On A Potential Monkeypox Vaccine May 24, 2022 As cases of monkeypox continue to rise, Moderna Inc (NASDAQ: MRNA) is probably working on its platform towards finding a vaccine shot against the disease. Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.